HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Calcibiotic Root Canal Sealer

Also Known As:
CRCS
Networked: 1073 relevant articles (27 outcomes, 133 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Goel, Ajay: 23 articles (10/2015 - 01/2004)
2. Boland, C Richard: 21 articles (10/2015 - 01/2004)
3. Kang, Gyeong Hoon: 15 articles (01/2016 - 12/2009)
4. Nagasaka, Takeshi: 15 articles (01/2014 - 11/2003)
5. Vernon, Sally W: 13 articles (12/2015 - 01/2006)
6. Imai, Kohzoh: 13 articles (10/2015 - 10/2004)
7. Yamamoto, Hiroyuki: 12 articles (09/2015 - 10/2004)
8. Bae, Jeong Mo: 11 articles (01/2016 - 01/2011)
9. Kim, Jung Ho: 11 articles (01/2016 - 12/2009)
10. Suzuki, Hiromu: 11 articles (10/2015 - 07/2005)

Related Diseases

1. Neoplasms (Cancer)
06/01/2011 - "Moreover, our results demonstrated that molecular screening and subsequent instrumental surveillance are very effective in identifying CRCs at earlier stages and reducing the number of deaths from secondary cancers in HNPCC patients."
01/01/2009 - "Two RCTs from the United Kingdom and Denmark showed significant reduction in CRC mortality using unrehydrated gFOBT biennially Relative risk reductions of 13% (UK trial) and 16% (Danish trial); absolute difference of 0.1% (UK trial) and 0.2% (Danish trial).No significant reduction in overall mortalityInterval cancers (CRC that develop in the intervals between routine screening) UNITED KINGDOM TRIAL: 236 CRCs detected by positive test, 236 interval CRCs after negative testDANISH TRIAL: 120 CRCs detected by positive test, 146 interval CRCs after negative testUnrehydrated gFOBT has low sensitivity for CRC detection (45% in the UK trial and 54% in the Danish trial). "
01/01/2014 - "CRCs with MYC over-expression demonstrated improved 5-year survival (93.2% vs. 57.3%), with the effect significantly modulated by the dominant effect of tumor stage, age at diagnosis and lymphovascular space invasion status on survival. "
06/01/2010 - "In both MMR-proficient CRC subgroups high frequency tumor-infiltrating FOXP3(+) T(reg) was associated with early T stage (p = 0.001 and <0.001), tumor location (p = 0.01 and 0.045) and increased 5-year survival rate (p = 0.004 and <0.001), whereas in MMR-deficient CRCs an association between FOXP3(+) T(reg) and absence of lymph node involvement (p = 0.023), absence of vascular invasion (p = 0.023) and improved 5-year survival rate (p = 0.029) could be detected. "
01/01/2014 - "Together, these compounds might enhance our ability to properly resect CRCs through better localization of the primary tumor and improved lymph node identification as well as detect distant disease."
2. Colorectal Neoplasms (Colorectal Cancer)
3. Adenoma (Adenomas)
4. Microsatellite Instability
5. Polyps

Related Drugs and Biologics

1. N-methylsuccinimide
2. Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
3. DNA (Deoxyribonucleic Acid)
4. Thymidylate Synthase
5. Fluorouracil (Carac)
6. Cytidine Triphosphate (CTP)
7. Retinoids
8. Adrenal Cortex Hormones (Corticosteroids)
9. PLX4032
10. Proteins (Proteins, Gene)

Related Therapies and Procedures

1. Adjuvant Chemotherapy
2. Orthoptics (Orthoptic)
3. Drug Therapy (Chemotherapy)
4. Immunotherapy
5. Therapeutics